- Home
- RLMD vs FWRG Comparison
RLMD vs FWRG Comparison
Compare RLMD & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLMD | FWRG |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.9M | 745.9M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RLMD | FWRG |
|---|---|---|
| Price | $6.69 | $12.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $12.40 | ★ $20.46 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.28 | 3.33 |
| EPS | N/A | ★ N/A |
| Revenue | $13,070.00 | ★ $1,222,501,000.00 |
| Revenue This Year | N/A | $15.58 |
| Revenue Next Year | N/A | $12.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 154.83 | 20.34 |
| 52 Week Low | $0.55 | $9.97 |
| 52 Week High | $8.00 | $19.53 |
Technical Indicators
Market Signals| Indicator | RLMD | FWRG |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 61.89 |
| Support Level | $6.17 | $10.22 |
| Resistance Level | $7.46 | $13.82 |
| Average True Range (ATR) | 0.45 | 0.67 |
| MACD | 0.03 | 0.16 |
| Stochastic Oscillator | 60.47 | 96.65 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
About FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. The company generates revenues from Restaurant sales and Franchise revenues. It generates maximum revenue from Restaurant sales.